Financials

  • Market Capitalization 263.51 M
  • Employee 44
  • Founded 2015
  • CEO N/A
  • Website www.surrozen.com
  • Headquarter Delaware, United States
  • FIGI BBG00XY94S95
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.66
Rapporto prezzo/fatturato
0.04

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3420
PYXS
Pyxis Oncology, Inc. - Common Stock
3.23 USD-2.71%+6.95%+19.63%+152.34%269.41 M USD
3427
SION
Sionna Therapeutics, Inc. - Common Stock
5.87 USD-3.14%+11.17%-87.47%-85.08%265.40 M USD
3433
WHWK
Whitehawk Therapeutics, Inc. - Common Stock
4.62 USD-5.13%-2.53%+19.38%+53.49%263.38 M USD
3436
MGNX
MacroGenics, Inc. - Common Stock
4.13 USD+1.23%+1.47%+11.02%+133.33%263.08 M USD

Notizie